52-Week Efficacy of Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis Who Failed Corticosteroids and/or Immunosuppressants

Title
52-Week Efficacy of Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis Who Failed Corticosteroids and/or Immunosuppressants
Authors
Keywords
-
Journal
INFLAMMATORY BOWEL DISEASES
Volume 19, Issue 8, Pages 1700-1709
Publisher
Oxford University Press (OUP)
Online
2013-05-10
DOI
10.1097/mib.0b013e318281f2b7

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started